BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• HepaRegeniX GmbH Raises €9 Million In A Series A Financing To Develop Kinase Inhibitors For The Treatment Of Acute And Chronic Liver Diseases

  January 5, 2017

   · 

  2 min read
• Business

  Rexgenero Announces Formation Of Scientific Advisory Board

  January 5, 2017

   · 

  7 min read
• Business

  CiVi Biopharma Receives Worldwide Exclusive License To Develop A Novel, RNA Targeted Drug Against PCSK-9

  January 5, 2017

   · 

  3 min read
• Biotech Bay

  Bay Area’s Intuity Med Ups Series 3 Funding to $55 Million With an Additional Close of $15 Million

  January 5, 2017

   · 

  3 min read
• Drug Development

  Halozyme Announces Phase 2 Study In Advanced Pancreas Cancer Meets Key Endpoints

  January 5, 2017

   · 

  7 min read
• Biotech Bay

  Sangamo Announces FDA Clearance Of Investigational New Drug Application For SB-525 Gene Therapy Program For Hemophilia A

  January 5, 2017

   · 

  5 min read
• Drug Development

  Synthetic Biologics’ SYN-004 (Ribaxamase) Achieves Primary Endpoint In Phase 2b Trial For C. Difficile Infection (CDI)

  January 5, 2017

   · 

  9 min read
• Business

  Phenex Pharmaceuticals AG Receives $100M Milestone Payment From Gilead

  January 5, 2017

   · 

  2 min read
• Drug Development

  CTI BioPharma Announces Removal Of Full Clinical Hold On Pacritinib

  January 5, 2017

   · 

  9 min read
• BioMidwest

  Cincinnati Children’s Hospital Medical Center Release: Scientists Tissue-Engineer Part Of Human Stomach In Laboratory

  January 5, 2017

   · 

  4 min read